Display Settings:

Format

Send to:

Choose Destination
    Nat Genet. 2009 Sep;41(9):991-5. Epub 2009 Aug 2.

    Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.

    Erratum in

    • Nat Genet. 2009 Oct;41(10):1156. Guarrera, Simonetta [added]; Polidoro, Silvia [added].

    Abstract

    We conducted a genome-wide association study on 969 bladder cancer cases and 957 controls from Texas. For fast-track validation, we evaluated 60 SNPs in three additional US populations and validated the top SNP in nine European populations. A missense variant (rs2294008) in the PSCA gene showed consistent association with bladder cancer in US and European populations. Combining all subjects (6,667 cases, 39,590 controls), the overall P-value was 2.14 x 10(-10) and the allelic odds ratio was 1.15 (95% confidence interval 1.10-1.20). rs2294008 alters the start codon and is predicted to cause truncation of nine amino acids from the N-terminal signal sequence of the primary PSCA translation product. In vitro reporter gene assay showed that the variant allele significantly reduced promoter activity. Resequencing of the PSCA genomic region showed that rs2294008 is the only common missense SNP in PSCA. Our data identify rs2294008 as a new bladder cancer susceptibility locus.

    PMID:
    19648920
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3313685
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Figure 1
    Figure 2

    Publication Types, MeSH Terms, Substances, Grant Support

      Supplemental Content

      Icon for Nature Publishing Group Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk